Overcoming poor permeability – the role of prodrugs for oral drug delivery

Amidon, 1995, A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res., 12, 413, 10.1023/A:1016212804288 A number of comprehensive reviews have been published: a. Rautio, J., ed. (2011) Prodrugs and Targeted Delivery, Volume 47 in Methods and Principles in Medicinal Chemistry. Wiley–CH; b. Stella, V.J. et al., ed. (2007) Prodrugs: Challenges and Rewards, Vol. 5 in Biotechnology: Pharmaceutical Aspects. Springer–AAPS Press; c. Boddu, S.H.S. et al. (2011) Prodrug strategies to enhance oral drug absorption. In Oral Bioavailability: Basic Principles, Advanced Concepts, and Applications (Hu, M., Li, X., eds)), John Wiley & Sons Maag, 2007, Prodrugs of carboxylic acids, 3, 10.1007/978-0-387-49785-3_20 Marquis, 2009, Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues, J. Med. Chem., 52, 6599, 10.1021/jm900563e Liederer, 2006, Enzymes involved in the bioconversion of ester-based prodrugs, J. Pharm. Sci., 95, 1177, 10.1002/jps.20542 Huang, 2009, Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents, J. Med. Chem., 52, 4288, 10.1021/jm900230j Robson, 1965, Protonation equilibria and alkaline hydrolysis of glycine ethyl ester, Nature, 208, 265, 10.1038/208265a0 Tilley, 2007, Prodrugs of benzamidines, 189, 10.1007/978-0-387-49785-3_24 Sorbera, 2001, Melagatran and ximelagatran, Drugs Future, 26, 1155, 10.1358/dof.2001.026.12.649378 Reeh, 2007, N,N′-Dihydroxyamidines: a new prodrug principle to improve the oral bioavailability of amidines, J. Med. Chem., 50, 6730, 10.1021/jm701259d Bailey, 2000, How to make drugs orally active: a substrate template for peptide transporter PepT1, Angew. Chem. Int. Ed., 39, 506, 10.1002/(SICI)1521-3773(20000204)39:3<505::AID-ANIE505>3.0.CO;2-B Sun, 2010, Enhancing the intestinal absorption of molecules containing the polar guanidino functionality: a double-targeted prodrug approach, J. Med. Chem., 53, 624, 10.1021/jm9011559 Huttunen, 2009, The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption, J. Med. Chem., 52, 4142, 10.1021/jm900274q DiMauro, T.M. (2011) Metformin-cysteine prodrug. US Pat. Appl. 20110257432 A1 Hirpara, 2009, Quercetin and its derivatives: synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability, Anti-Cancer Agents Med. Chem., 8, 138, 10.2174/187152009787313855 Ninomiya, 2011, Increased bioavailability of tricin-amino acid derivatives via a prodrug approach, J. Med. Chem., 54, 1529, 10.1021/jm1015457 Kim, 2009, In vitro solubility, stability and permeability of novel quercetin–amino acid conjugates, Bioorg. Med. Chem., 17, 1164, 10.1016/j.bmc.2008.12.043 Li, 2007, Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting, J. Pharm. Sci., 1 Song, 2004, Amino acid ester prodrugs of the anticancer agent Gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport, Mol. Pharm., 2, 157, 10.1021/mp049888e Bender, 2009, Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine, J. Med. Chem., 52, 6958, 10.1021/jm901181h Jonckers, 2010, 2′-Deoxy-2′-spirocyclopropylcytidine revisited: a new and selective inhibitor of the hepatitis C virus NS5B polymerase, J. Med. Chem., 53, 8150, 10.1021/jm101050a Naesens, 1998, Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethylpropyl)adenine in mice, Antimicrob. Agents Chemother., 42, 1568, 10.1128/AAC.42.7.1568 Mehellou, 2009, Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells, ChemMedChem, 4, 1779, 10.1002/cmdc.200900289 Sofia, 2010, Discovery of a β-d-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus, J. Med. Chem., 53, 7202, 10.1021/jm100863x McGuigan, 2011, Phosphorodiamidates as a promising new phosphate prodrug motif for antiviral drug discovery: application to anti-HCV agents, J. Med. Chem., 54, 8632, 10.1021/jm2011673 Baudy, 2009, Prodrugs of perzinfotel with improved oral bioavailability, J. Med. Chem., 52, 771, 10.1021/jm8011799 Dhareshwar, 2008, Your prodrug releases formaldehyde: Should you be concerned? No!, J. Pharm. Sci., 97, 4184, 10.1002/jps.21319 Dang, 2011, Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase, J. Med. Chem., 54, 153, 10.1021/jm101035x